A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State
Clinical trial NCT07030439 · COMPLETED
Trial details
- NCT number
- NCT07030439
- Sponsor
- Impact Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-18
- Primary completion
- 2021-10-12
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.